Actively Recruiting
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
Led by Metrolina Eye Associates, PLLC · Updated on 2025-10-29
105
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
Sponsors
M
Metrolina Eye Associates, PLLC
Lead Sponsor
A
Alcon, a Novartis Company
Collaborating Sponsor
AI-Summary
What this Trial Is About
Phacoemulsification (cataract surgery) is usually performed while temporarily increasing the pressure inside the eye. The purpose of this study is to see if maintaining different pressure levels inside the eye during this procedure results in fewer side effects and better vision shortly after the surgery. Cataract surgery will be performed using Unity VCS at a lower IOP in one eye compared to traditional IOP with Centurion Vision System with Ozil in the other eye. Both of which are approved by the United States Food and Drug Administration (FDA) and used per label.
CONDITIONS
Official Title
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have cataracts
You will not qualify if you...
- Have glaucoma
- Have cornea disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Metrolina Eye Associates
Matthews, North Carolina, United States, 28105
Actively Recruiting
Research Team
I
IVAN MAC, MD
CONTACT
M
Megan Lee
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here